Kestra Medical Technologies, Ltd. Operating Expenses
Kestra Medical Technologies, Ltd. (KMTS) reported Operating Expenses of $55.16 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. operating expenses for the quarter ending 2026-07-31 was $55.16M, a 46.19% increase year-over-year.
- Kestra Medical Technologies, Ltd. operating expenses for the quarter ending 2026-04-30 was $55.03M, a 1.47% decline year-over-year.
- Kestra Medical Technologies, Ltd. operating expenses for the quarter ending 2026-01-31 was $47.67M, a 75.60% increase year-over-year.
- Kestra Medical Technologies, Ltd. operating expenses for the quarter ending 2025-10-31 was $43.18M, a 72.97% increase year-over-year.
- Kestra Medical Technologies, Ltd. operating expenses for fiscal 2026 was $183.60M, a 40.60% increase from fiscal 2025.
- Kestra Medical Technologies, Ltd. operating expenses for fiscal 2025 was $130.59M, a 52.87% increase from fiscal 2024.
- Kestra Medical Technologies, Ltd. operating expenses for fiscal 2024 was $85.42M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-07-31 | $55.16M 10-Q · filed 2026-09-14 | $110.18M derived: sum of 2 quarters · filed 2026-09-14 | $157.85M derived: sum of 3 quarters · filed 2026-09-14 | $201.03M derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | $55.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $102.70M derived: sum of 2 quarters · filed 2026-07-14 | $145.88M derived: sum of 3 quarters · filed 2026-07-14 | $183.60M 10-K · filed 2026-07-14 |
| 2026-01-31 | $47.67M 10-Q · filed 2026-03-17 | $90.85M derived: sum of 2 quarters · filed 2026-03-17 | $128.58M 10-Q · filed 2026-03-17 | $184.42M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | $43.18M 10-Q · filed 2025-12-11 | $80.91M 10-Q · filed 2025-12-11 | $136.75M derived: sum of 3 quarters · filed 2026-09-14 | $163.90M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | $37.73M 10-Q · filed 2026-09-14 | $93.57M derived: sum of 2 quarters · filed 2026-09-14 | $120.72M derived: sum of 3 quarters · filed 2026-09-14 | $145.69M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | $55.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $82.99M derived: sum of 2 quarters · filed 2026-07-14 | $107.96M derived: sum of 3 quarters · filed 2026-07-14 | $130.59M 10-K · filed 2026-07-14 |
| 2025-01-31 | $27.15M 10-Q · filed 2026-03-17 | $52.11M derived: sum of 2 quarters · filed 2026-03-17 | $74.74M 10-Q · filed 2026-03-17 | |
| 2024-10-31 | $24.96M 10-Q · filed 2025-12-11 | $47.59M 10-Q · filed 2025-12-11 | ||
| 2024-07-31 | $22.63M 10-Q · filed 2025-09-12 | |||
| 2024-04-30 | $85.42M 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |